Compare · Healing peptide
BPC-157 vs Thymosin Beta-4
Both are healing peptide compounds. Here's how they line up on the evidence — graded the same way.
| BPC-157 | Thymosin Beta-4 | |
|---|---|---|
| Evidence | 4/10 | 6/10 |
| Class | Healing peptide | Healing peptide |
| Summary | A synthetic peptide marketed for healing, but human data is limited to a few tiny uncontrolled studies. It is unapproved and banned in sport. | Full-length thymosin beta-4 has genuine human trials for eye-surface and wound healing, but the evidence is small, sponsor-driven, and largely missed its primary endpoints. |
| Full profile → | Full profile → |
BPC-157
BPC-157 is one of the most hyped "healing peptides" in the recovery and longevity world. But once you set the marketing aside, there is surprisingly little human evidence to back it up.
Thymosin Beta-4
Thymosin beta-4 stands out from most "research peptides" for one simple reason: it has actually gone through real, registered, peer-reviewed human trials. That is its honest claim to fame. But it is also where the story gets complicated, because its most-studied use has now fallen short of its main…